Related Experiment Video
Updated: May 24, 2026

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Epigenetic disruption of cadherin-11 in human cancer metastasis
F Javier Carmona1, Alberto Villanueva, August Vidal
1Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Abstract:
Little is known about the molecular events occurring in the metastases of human tumours. Epigenetic alterations are dynamic lesions that change over the natural course of the disease, and so they might play a role in the biology of cancer cells that have departed from the primary tumour. Herein, we have adopted an epigenomic approach to identify some of these changes. Using a DNA methylation microarray platform to compare paired primary tumour and lymph node metastatic cell lines from the same patient, we observed cadherin-11 promoter CpG island hypermethylation as a likely target of the process. We found that CDH11 DNA methylation-associated transcriptional silencing occurred in the corresponding lymph node metastases of melanoma and head and neck cancer cells but not in the primary tumours. Using in vitro and in vivo cellular and mouse models for depleted or enhanced CDH11 activity, we also demonstrated that CDH11 acts as an inhibitor of tumour growth, motility and dissemination. Most importantly, the study of CDH11 5'-CpG island hypermethylation in primary tumours and lymph node metastases of cancer patients showed this epigenetic alteration to be significantly confined to the disseminated cells. Overall, these results indicate the existence of metastasis-specific epigenetic events that might contribute to the progression of the disease.
Insights
Epigenetic changes, like cadherin-11 (CDH11) promoter hypermethylation, are specific to cancer metastases. This silencing of CDH11 inhibits tumor growth and spread, offering insights into cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- The molecular mechanisms driving cancer metastasis remain largely unknown.
- Epigenetic alterations are dynamic and may influence cancer cell behavior during disease progression.
Purpose of the Study:
- To investigate metastasis-specific epigenetic changes in human tumors.
- To identify molecular targets involved in the biology of disseminated cancer cells.
Main Methods:
- Utilized a DNA methylation microarray to compare paired primary tumors and lymph node metastases.
- Employed in vitro and in vivo models to assess the functional role of cadherin-11 (CDH11).
- Analyzed CDH11 5'-CpG island hypermethylation in patient samples.
Main Results:
- Identified cadherin-11 (CDH11) promoter CpG island hypermethylation in lymph node metastases but not primary tumors.
- Demonstrated CDH11 DNA methylation-associated transcriptional silencing in melanoma and head and neck cancer metastases.
- Showed that CDH11 inhibits tumor growth, motility, and dissemination in experimental models.
- Found CDH11 hypermethylation significantly confined to disseminated cancer cells in patients.
Conclusions:
- Epigenetic alterations, specifically CDH11 promoter hypermethylation, are associated with cancer metastasis.
- CDH11 acts as a tumor suppressor, inhibiting growth and spread.
- These findings reveal metastasis-specific epigenetic events crucial for disease progression.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Structure of Cadherins
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
